The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 2-10B Indolent Lymphoma: Prognostic Factors

Sat. Oct 12, 2019 10:10 AM - 11:10 AM No.10 (Tokyo International Forum, 4F G409)

Chair: Noriko Fukuhara (Tohoku University Hospital, Department of Hematology and Rheumatology)

[OS2-10B-5] A phase II study of GCD +/- rituximab in patients with relapsed or refractory non-Hodgkin lymphoma

Takuro Matsumoto1, Junichi Kitagawa1, Yuto Kaneda1, Kimihiro Yamaguchi1, Nobuhiko Nakamura1, Nobuhiro Kanemura1,2, Michio Sawada3, Takeshi Hara1,4, Masahito Shimizu1, Hisashi Tsurumi1,4 (1.Dept. Hematol., Gifu Univ. Grad. Sch. Med., Gifu, Japan, 2.Dept. Hematol., Chuno Kosei Hospital, Gifu, Japan, 3.Dept. Hematol., Gifu Red Cross Hospital, Gifu, Japan, 4.Dept. Hematol., Matsunami General Hospital, Gifu, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password